ALS News

Researchers Find a Specific Biomarker for ALS that May Improve the Diagnostic Process

ALS NEWS - January 19, 2021

Diagnosing Amyotrophic Lateral Sclerosis (ALS) can take between 9 to 12 months. Finding a “biomarker” or a physical attribute that confirms ALS onse... Read More

Medication Using Gold Crystals with Promising Potential for ALS Treatment

ALS NEWS - January 19, 2021

Over 40% of the participants in the phase 2 clinical trial for CNM-Au8 show improvements in health. CNM-AU8 is a gold nanocrystal suspension treatment designed ... Read More

New ALS Disability Bill Passed Congress, Waving the Five-Month Waiting Period for Social Security Disability Insurance

ALS NEWS - December 08, 2020

After 4 years of challenging work and 54,000 phone calls, letters, and emails to Congress from advocates like you, Congress passed a law that wai... Read More

FDA Grants Orphan Drug Status to Promising Treatment for ALS Called SLS-005

ALS NEWS - November 25, 2020

Seelos Therapeutics is working on a treatment called SLS-005 or trehalose to treat Amyotrophic Laterals Sclerosis. The drug proves to be eff... Read More

What is Gene Therapy and How is it Changing the Future for ALS?

ALS NEWS - October 29, 2020

Amyotrophic lateral sclerosis, or ALS, is a neurological disease that causes the death of motor neurons. More commonly known as Lou Gehrig’s disease, ALS ... Read More

A New Advancement in Gene Therapy for ALS Patients

ALS NEWS - October 27, 2020

In a press release this week Ionis Pharmaceuticals, a leader in gene therapy treatments, announced its first gene therapy medication designed to treat... Read More

Small ALS Research Teams are Breaking New Ground in ALS Treatment

ALS NEWS - October 19, 2020

Life with ALS is not an easy one. There are only a small number of treatments available for those diagnosed with this rapidly progressing neurological... Read More

Phase II ALS Clinical Trial Produces Promising Results for AMX0035

ALS NEWS - September 29, 2020

The Pharmaceutical company AMYLYX recently released promising results for the ALS drug AMX0035 after Phase II clinical trials were completed. The results d... Read More

New Promising Neurological Treatment for Alzheimer's used in ALS in Phase 2 Clinical Trials

ALS NEWS - September 13, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More

A Potential ALS Treatment is Back on Track After COVID-19 Disruption

ALS NEWS - August 31, 2020

This global pandemic has put a lot of things on pause. From sports to drug research, the world is doing a complete reboot. One of the biggest setbacks is fundin... Read More

Clene Nanomedicine Develops New Therapy for ALS Using Gold Nanocrystals

ALS NEWS - August 29, 2020

Clene Nanotechnologies, a Utah based company, has developed a nano-therapetic for neurodegenerative disorders including ALS. To date, Clene's preclinical tr... Read More

New Promising Neurological Treatment Involves ALS in Phase 2 Clinical Trials

ALS NEWS - August 28, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More

ALS Clinical Trials Actively Recruiting

ALS NEWS - August 05, 2020

ALS Crowd is dedicated to connecting researchers, doctors, patients, and caregivers/family members in order to support, educate, and find patterns in therapy to... Read More